Symbols / AAIC
AAIC Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Roche shares promising data from Alzheimer’s disease development portfolio - PMLiVE ue, 29 Jul 2025 07
- Anavex Reports Breakthrough: Oral Alzheimer's Drug Maintains Benefits After 4 Years as Cash Position Tops $100M - Stock Titan ue, 12 Aug 2025 07
- Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025 - Biogen Mon, 21 Jul 2025 07
- INmune Bio shares slide after Phase II Alzheimer’s trial misses endpoints - Clinical Trials Arena ue, 01 Jul 2025 07
- Roche Reveals New Data from Alzheimer’s Disease Research at AAIC 2025 - PharmTech.com Mon, 04 Aug 2025 07
- Assured Guaranty Becomes Oversold - Nasdaq ue, 13 Jan 2026 08
- Genentech and Roche Present New Insights in Alzheimer’s Disease Research Across Its Diagnostics and Pharmaceutical Portfolios at AAIC - Yahoo Finance Sun, 27 Jul 2025 07
- Ellington Financial Agrees To Acquire AAIC - National Mortgage Professional Wed, 31 May 2023 07
- CGTX Stock Surge: Deciphering the Spike - StocksToTrade Wed, 13 Aug 2025 07
- Lilly's Kisunla (donanemab-azbt) showed growing benefit over three years in early symptomatic Alzheimer's disease - Yahoo Finance Wed, 30 Jul 2025 07
- Proposed SNAP Cuts Could Threaten Prevention for Cognitive Decline, Dementias - AJMC Wed, 30 Jul 2025 07
- NIH-funded researchers preview preliminary clinical trial results at AAIC suggesting aggressive blood pressure control may lower risk of cognitive impairment - nhlbi, nih (.gov) Wed, 25 Jul 2018 07
- Cognition Therapeutics’ stock dips 43% following trial results for Alzheimer’s candidate - Clinical Trials Arena ue, 30 Jul 2024 07
- Eli Lilly and Biogen/Eisai’s extension trials make waves in Alzheimer’s market - Yahoo Finance hu, 31 Jul 2025 07
- Zanifu raises $11.2M to scale its inventory financing offering in Kenya - TechCrunch Mon, 21 Aug 2023 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AAIC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|